A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes.

MLA

Hornbak, Malene, et al. “A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes.” PLoS ONE, vol. 9, no. 8, Aug. 2014, p. 1. EBSCOhost, https://doi.org/10.1371/journal.pone.0104837.

APA

Hornbak, M., Allin, K. H., Jensen, M. L., Lau, C. J., Witte, D., Jørgensen, M. E., Sandbæk, A., Lauritzen, T., Andersson, Å., Pedersen, O., & Hansen, T. (2014). A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes. PLoS ONE, 9(8), 1. https://doi.org/10.1371/journal.pone.0104837

Chicago

Hornbak, Malene, Kristine Højgaard Allin, Majken Linnemann Jensen, Cathrine Juel Lau, Daniel Witte, Marit Eika Jørgensen, Annelli Sandbæk, et al. 2014. “A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes.” PLoS ONE 9 (8): 1. doi:10.1371/journal.pone.0104837.